Clearside biomedical announces plan to explore strategic alternatives to advance its proprietary suprachoroidal space (scs®) delivery platform and promising ophthalmology pipeline

- proven in-office, repeatable, non-surgical procedure for the targeted delivery of a wide variety of therapies for serious retinal diseases -

SCS Ratings Summary

SCS Quant Ranking